Refine by
Printing Pro Solution Articles & Analysis: Older
10 news found
Prellis Biologics announced today that it has closed a $14.5 million Series B financing round, led by Celesta Capital and current investor Khosla Ventures Prellis will use the proceeds to advance its Externalized Immune System (EXIS™) platform, a first-in-class in vitro, fully human antibody discovery, and vaccine screening workflow. “The EXIS platform offers unprecedented in vitro ...
Prellis Biologics announced today that it has closed a $14.5 million Series B financing round, led by Celesta Capital and current investor Khosla Ventures Prellis will use the proceeds to advance its Externalized Immune System (EXIS™) platform, a first-in-class in vitro, fully human antibody discovery, and vaccine screening workflow. “The EXIS platform offers unprecedented in vitro ...
Axial3D, an award-winning medical imaging technology company, headquartered in Belfast has announced a partnership with BIOMODEX®, the leader in biorealistic haptic simulators for physician training and rehearsals. The partnership will enable Biomodex to speed the production of 3D-printed brain aneurysm models by reducing the time it takes to transform 2D medical images to 3D visuals. An ...
ByAxial3D
BIOMODEX, a pioneering digital health company that offers a unique and enhanced 3D printed solution for physician training, announced today the company has partnered with two of the top medical centers in France and a world-class health system in the United States to develop EVIAS Plus - an innovative training solution for treatment of ischemic stroke. Ischemic stroke accounts for about 87 ...
ByBIOMODEX
MUNICH, Germany – February 4th, 2020: In the future, novel polymers should make it possible to individually manufacture artificial elastic tissue replacements for pericardium, heart valves or blood vessels. In the PolyKARD project, biomimetic polymers are being developed that can imitate the mechanical properties of pericardial tissue. Using 3D printing and electrospinning, these ...
Poietis, 4D Bioprinting company, announces the issuance by the European Patent Office of a third patent covering its bioprinting technology: Patent No. EP3233499 entitled «Laser printing method and device for implementing said method», which covers in particular the process of bioprinting upwards, previously delivered in France, and in Europe on March 21st, 2019. As a reminder ...
ByPoietis
The Prime Minister Theresa May and Chancellor of the Exchequer Philip Hammond visited Renishaw's headquarters site near Wotton-under-Edge in Gloucestershire, yesterday (24th November) for a tour of the company's main research and development (R&D) facilities. Following a meeting with senior Renishaw directors, the Prime Minister and Chancellor of the Exchequer toured the company's Innovation ...
Global precision engineering company Renishaw plc has announced a new Healthcare Centre of Excellence at its Miskin site, located close to Cardiff, South Wales. The Centre, which was formally opened on 29th September by The Rt Hon Carwyn Jones AM, First Minister of Wales, provides a facility for the manufacture of custom medical devices, as well as education and training for the life sciences ...
Additive-manufacture for Design-led Efficient Patient Treatment (ADEPT) has been shortlisted for a Collaborate to Innovate award, in the Health and Wellbeing category. The collaborative project aims to revolutionise maxillofacial implants through design and laser melting by drawing on expertise from several partners, including global engineering company Renishaw. The awards, organised by The ...
Brady Worldwide, Inc. (NYSE: BRC), a trusted provider for laboratory labeling, is pleased to introduce a new specimen labeling system for histology and anatomic pathology labs – the Brady Specimen Labeling Solution. With a revolutionary label attachment system and durable labels that withstand tissue processing and last up to 20 years in storage, Brady’s Specimen Labeling Solution is an ...